biotech thread - wednesday 5th june, page-7

ALT

In a trading halt pending news of their Taiwan distribution

If they confirm they have secured it, well worth a look when it resumes guys.

Burn from memory is around $1.2M per year. So if it is in line with Brazil estimates of $3-4M they are straight off the bat cashflow positive.

Draft Brazilian distribution agreement already received, so very likely may secure a 2nd international deal.

Both deals I'd estimate to be worth minimum $6M p.a to them based on WiseOwl's forecasts

Market cap $11M, so on the inital $3M I'd say $20M+ cap is fair